查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493325

美國IVF 市場規模、佔有率和趨勢分析報告：按設備、程序類型、最終用途和細分市場進行預測，2024-2030 年

U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國試管嬰兒市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2024年至2030年美國IVF市場規模將以4.4%的複合年成長率成長，2030年將達到72.4億美元。

婚姻不孕症的日益普遍、體外受精技術和方法的不斷進步以及社會規範和對家庭的態度的變化是美國對體外受精服務需求增加的主要原因。

圍繞輔助生殖技術（包括體外受精）的監管環境也在影響市場動態。管理 IVF 實踐、診所認證標準和道德考慮的法規影響著美國IVF 服務的可及性和品質。監管變化可以透過影響治療成本、診所運作和病人安全等因素來促進或阻礙市場成長。

提高大眾對不孕症問題和可用治療方法的認知在推動美國試管嬰兒市場的成長中發揮關鍵作用。教育宣傳活動、媒體報導和宣傳工作正在幫助使不孕症變得非人性化，並促進對體外受精等不孕症治療的理解。隨著認知的提高，人們現在可以就透過體外受精治療不孕症做出明智的決定。

美國試管嬰兒市場報告亮點

  • 從設備來看，文化傳媒領域將在2023年佔據市場主導地位，佔有率約40%。
  • 拋棄式設備領域預計在預測期內將以最快的複合年成長率成長。
  • 根據手術類型，新鮮的非捐贈者細分市場佔據最大市場佔有率，到 2023 年將超過 45%。新鮮週期通常被認為具有成本效益，因為實現成功懷孕可能需要更少的治療週期。
  • 由於其便利性和靈活性，冷凍捐贈者預計在預測期內將實現最快的複合年成長率。
  • 2023年，生育診所市場約佔80%的佔有率，預計在預測期內將以最快的複合年成長率成長。
  • 對 ART 治療的需求不斷增加，導致生育診所和 ART 中心的數量大幅增加。
  • 2023年10月，默克公司宣布啟動生育福利計劃，旨在為員工提供生育治療的金融服務。服務範圍包括體外受精治療、不孕症測試和荷爾蒙治療。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國IVF 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國IVF市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國試管嬰兒市場：設備估算及趨勢分析

  • 2023年及2030年設備市場佔有率
  • 細分儀表板
  • 按設備分類的美國IVF 市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 拋棄式培養基
  • 培養基
  • 主要設備

第5章美國IVF市場：治療類型估算及趨勢分析

  • 2023 年和 2030 年按治療類型市場佔有率
  • 細分儀表板
  • 美國IVF 市場：依手術類型分類的前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 新的捐贈者
  • 冷凍供體
  • 新鮮的非捐贈者
  • 冷凍非捐贈者

第6章美國IVF 市場：最終用途估算與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的美國IVF 市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 設施診所
  • 醫院及其他環境

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 公司簡介
    • Bayer AG
    • Cook Medical LLC
    • EMD Serono, Inc.
    • Ferring BV
    • FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporation）
    • Genea Biomedx
    • EMD Serono, Inc.（Merck KGaA）
    • Merck &Co., Inc.
    • The Cooper Companies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Vitrolife
    • Nova IVF
    • RMA Network（Reproductive Medicine Associates）
    • US Fertility
Product Code: GVR-4-68040-278-5

U.S. In Vitro Fertilization Market Growth & Trends:

The U.S. in vitro fertilization market size is anticipated to reach USD 7.24 billion by 2030, expanding at a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infertility among couples, the continuous advancements in IVF technology and techniques, and the shift in societal norms and attitudes toward family have significantly contributed to the increasing demand for IVF services in the U.S.

The regulatory landscape surrounding assisted reproductive technologies, including IVF, also influences market dynamics. Regulations governing IVF practices, clinic accreditation standards, and ethical considerations impact the accessibility and quality of IVF services in the U.S. Changes in regulations can either facilitate or hinder market growth by affecting factors such as treatment costs, clinic operations, and patient safety.

Increased public awareness about infertility issues and available treatment options has played a crucial role in driving the growth of the U.S. IVF market. Educational campaigns, media coverage, and advocacy efforts have helped destigmatize infertility and promote understanding about fertility treatments like IVF. Greater awareness empowers individuals to make informed decisions about seeking fertility assistance through IVF.

U.S. In Vitro Fertilization Market Report Highlights:

  • Based on instruments, the culture media segment dominated the market with around 40% share in 2023 owing to as availability of funding and an increase in research activities
  • The disposable devices segment is expected to grow at the fastest CAGR over the forecast period
  • Based on procedure type, the fresh non-donor segment held the largest market share of over 45% in 2023. Fresh cycles are often perceived as more cost-effective due to potentially requiring fewer treatment cycles to achieve a successful pregnancy
  • Frozen donors are expected to register the fastest CAGR during the forecast period owing to the convenience and flexibility offered by them
  • The fertility clinics segment dominated the market with around 80% share in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • The increasing demand for ART treatments has led to a significant rise in the number of fertility clinics and ART centers
  • In October 2023, Merck & Co. announced the launch of Fertility benefit program with the aim to provide financial services to employees for fertility treatments. The range of services includes IVF treatments, fertility tests, and hormonal treatments

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Instrument
    • 1.2.2. Procedure type
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Instrument outlook
    • 2.2.2. Procedure type
    • 2.2.3. End-use
  • 2.3. Competitive Insights

Chapter 3. U.S. In Vitro Fertilization Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. In Vitro Fertilization Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. In Vitro Fertilization Market: Instrument Estimates & Trend Analysis

  • 4.1. Instrument Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. In Vitro Fertilization Market by Instrument Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 4.4.1. Disposable media
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Culture media
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Cryopreservation Media
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Embryo culture media
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Ovum Processing Media
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Sperm Processing Media
      • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Capital Equipment
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Sperm Analyzer Systems
      • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Imaging Systems
      • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.4. Ovum Aspiration Pumps
      • 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.5. Micromanipulator Systems
      • 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.6. Incubators
      • 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.7. Gas Analyzers
      • 4.4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.8. Laser Systems
      • 4.4.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.9. Cryosystems
      • 4.4.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.10. Sperm Separation Devices
      • 4.4.3.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.11. IVF Cabinets
      • 4.4.3.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.12. Anti-vibration Tables
      • 4.4.3.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.13. Witness Systems
      • 4.4.3.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.14. Other
      • 4.4.3.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis

  • 5.1. Procedure Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. In Vitro Fertilization Market by Procedure Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Fresh Donor
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Frozen Donor
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Fresh Non-donor
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Frozen Non-donor
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. In Vitro Fertilization Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. In Vitro Fertilization Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.4.1. Fertility Clinics
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Hospitals & Others Setting
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company heat map analysis, 2023
  • 7.4. Company Profiles
    • 7.4.1. Bayer AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Cook Medical LLC
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. EMD Serono, Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Ferring B.V.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Genea Biomedx
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. EMD Serono, Inc. (Merck KGaA)
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Merck & Co., Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. The Cooper Companies, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Thermo Fisher Scientific, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Vitrolife
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Nova IVF
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiativesc
    • 7.4.13. RMA Network (Reproductive Medicine Associates)
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. U.S. Fertility
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. in vitro fertilization market, by instrument, 2018 - 2030 (USD Million)
  • Table 3 U.S. in vitro fertilization market, by procedure type, 2018 - 2030 (USD Million)
  • Table 4 U.S. in vitro fertilization market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. in vitro fertilization market: market outlook
  • Fig. 9 U.S. in vitro fertilization competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. in vitro fertilization market driver impact
  • Fig. 14 U.S. in vitro fertilization market restraint impact
  • Fig. 15 U.S. in vitro fertilization market: Instrument movement analysis
  • Fig. 16 U.S. in vitro fertilization market: Instrument outlook and key takeaways
  • Fig. 17 Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Disposable devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Culture Media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cryopreservation media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Embryo culture media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Ovum processing media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Sperm processing media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Capital equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Sperm analyzer systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Imaging systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ovum aspiration pumps market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Micromanipulator market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Gas analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Laser systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cryosystems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Sperm separation devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 IVF cabinets market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Anti - vibration tables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Witness systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. in vitro fertilization market: Procedure type movement Analysis
  • Fig. 39 U.S. in vitro fertilization market: Procedure type outlook and key takeaways
  • Fig. 40 Surgical ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Fresh donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Frozen donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Fresh non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Frozen non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. in vitro fertilization market: End - use outlook and key takeaways
  • Fig. 46 Fertility clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Hospitals and other settings market estimates and forecasts, 2018 - 2030 (USD Million)